What is DOW Testing?
MoonMD’s Diabetes, Obesity, and Weight (DOW) Panel leverages advanced Next-Generation Sequencing (NGS) technology to evaluate your genetic predisposition to diabetes and obesity—two of the most common metabolic health challenges worldwide. By identifying key genetic markers linked to these conditions, MoonMD enables early detection and personalized risk assessment. Unlike traditional tests that examine only a few genetic factors, our NGS-based approach offers a comprehensive and detailed analysis, transforming how diabetes and obesity are prevented, managed, and treated through precision medicine.
How Will I Benefit?
MoonMD’s DOW Panel provides a comprehensive genetic analysis to deliver an accurate assessment of your personal risk for diabetes and obesity. By identifying specific genetic variants linked to these conditions, MoonMD offers insights into your unique genetic makeup, empowering you to make informed lifestyle choices and take proactive steps to reduce your risk. Early detection through the panel also enables targeted interventions and personalized healthcare plans, helping you optimize your health and potentially prevent the development of diabetes and obesity.
What We Offer
MoonMD’s DOW Panel includes a carefully curated set of genes selected for their relevance to diabetes and obesity risk. Using NGS technology, we analyze multiple genes simultaneously, covering a wide range of genetic variations linked to these metabolic conditions. Your results include a detailed report with your individual risk factors, genetic insights, and actionable recommendations. With this knowledge, you can proactively manage your health, work with healthcare professionals on personalized prevention strategies, and make informed lifestyle choices. MoonMD empowers you with a comprehensive and accurate evaluation of your genetic predisposition, enabling you to take charge of your well-being and embrace personalized healthcare for a healthier future.
